IncomeSharks
IncomeSharks
IncomeSharks avatar

IncomeSharks

Stock
Crypto
Macro

Crypto and stock trader focused on fundamental analysis, trend analysis, and swing trading.

965Posts
1.7kComments
163%Best ROI
joined

Joined on 13th October 2025

Staples and Healthcare holding up well today

Seems this week we've seen both of these sectors starting to wake up. Investors might be looking for a place to rotate profits if they feel the markets have been exhausted. There's still a lot of speculation going on with Space X and liquidity and what that would look like or if it will be another massive catalyst.

$ORCL - Looks to have put in a bottom, formed support, breakout and re-test, and then pushing through higher here. Strong earnings and revenue forecasts which are helping with the recovery.

Sold 100%
Stop Loss : 230.82 $
Oracle Corporation

Oracle Corporation

3 Jun

CLOSEDLONG

Invested Capital

5%

Buying Price

191.8$

Selling Price

230.8$

ROI

20.36%

$CMPS - Fundamentals are a lot more speculative but the TA looks really good. Long term breaking out and one analyst even has $70+ targets.

This is a huge gamble as it's non revenue BUT if they get FDA approval or are able to go to commercial market and the results are good this quickly becomes a monster of a company. There could be a lot of push back by big pharma and there's a lot of risks on top of scheduling the drugs.

They've got 500 million to work with in cash, cash burn much slower, and it seems like they are positioned well to have a semi productive 2026/2027. Another Trump tweet or White House pushing more for rescheduling could obviously cause more hype.

Plan: 1% position on the breakout in case it never comes lower. Next play would be a 2% buy if we get way lower in the green and sit on it long term. The 3rd buy would be on momentum out of the buy zone or confirmation that it's got approval or massive insider buying/news shows up.

COMPASS Pathways plc

COMPASS Pathways plc

1 Jun

OPENLONG

Invested Capital

1%

Buying Price

14.54$

Current Price

-

ROI

0.00%